Back to top
more

Intuitive Surgical (ISRG)

(Delayed Data from NSDQ)

$506.34 USD

506.34
1,041,901

+2.50 (0.50%)

Updated Nov 1, 2024 03:59 PM ET

Pre-Market: $507.11 +0.77 (0.15%) 8:14 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (79 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Ensign Group Q3 Earnings Beat on Patient Days, Stock Up 4.1%

by Zacks Equity Research

ENSG's strong third-quarter earnings benefit from improved occupancy and skilled mix days. Higher expenses partially offset the positives.

Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It

by Zacks Equity Research

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

Teleflex Q3 Earnings Top, Stock Falls on Lowered 2024 Revenue Outlook

by Zacks Equity Research

TFX benefits from a diversified product portfolio in the third quarter of 2024, with strength in the Vascular Access and Interventional segments.

OMCL Stock Soars on Q3 Earnings & Revenue Beat, '24 EPS View Raised

by Zacks Equity Research

Omnicell continues its trend of impressive results in the third quarter of 2024.

Envista Stock Climbs on Q3 Earnings and Revenue Beat, Margins Crash

by Zacks Equity Research

NVST delivers better-than-expected top and bottom-line performance in the third quarter of 2024.

Cigna Q3 Earnings Beat on Client Wins & Specialty Business Strength

by Zacks Equity Research

CI's strong third-quarter results benefit from a strong Evernorth Health Services segment. Higher expenses partially offset the positives.

Is Brainsway (BWAY) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Brainsway Ltd. Sponsored ADR (BWAY) and Intuitive Surgical, Inc. (ISRG) have performed compared to their sector so far this year.

ZBH Stock Up Despite Q3 Earnings Miss, 2024 View Narrowed

by Zacks Equity Research

Zimmer Biomet delivers strong performance across segments and regions in the third quarter of 2024.

Centene Q3 Earnings Beat on Growth in Marketplace Business Line

by Zacks Equity Research

CNC's Q3 results benefit from growth in premiums, driven by strong product positioning. Despite higher revenues, declines in Medicaid membership and increased expenses weigh on profitability.

Universal Health Q3 Earnings Miss on Elevated Operating Costs

by Zacks Equity Research

UHS' Q3 results suffer from rising operating costs in salaries, wages and benefits, and supplies, impacting profitability. Nevertheless, strong revenue growth and increased admissions partly offset the downside.

ResMed's Stock Rises on Q1 Earnings and Revenue Beat, Margins Expand

by Zacks Equity Research

RMD's stellar first-quarter fiscal 2025 results reflect the ongoing momentum and strong execution across all areas of its business.

ALGN Q3 Earnings Top Estimates, Revenues Miss, Stock Falls

by Zacks Equity Research

Align Technology reports third-quarter 2024 revenue growth. This can be mostly attributed to a robust performance by the Imaging Systems & CAD/CAM Services business segment.

Intuitive Surgical (ISRG) Is Considered a Good Investment by Brokers: Is That True?

by Zacks Equity Research

Based on the average brokerage recommendation (ABR), Intuitive Surgical (ISRG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Thermo Fisher Q3 Earnings Top Estimates, Revenues Miss, Stock Dips

by Zacks Equity Research

In the third quarter of 2024, TMO continued to advance its growth strategy and trusted partner status with customers.

Company News for Oct 21, 2024

by Zacks Equity Research

Companies in The News Are: ISRG, SLB, PLTR, HAL

Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Compared to Estimates, Intuitive Surgical (ISRG) Q3 Earnings: A Look at Key Metrics

by Zacks Equity Research

While the top- and bottom-line numbers for Intuitive Surgical (ISRG) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Intuitive Surgical Q3 Earnings Beat, Procedures Robust

by Zacks Equity Research

ISRG's third-quarter results reflect a healthy demand for procedures. Higher pricing boosts procedure sales. An improvement in margins buoys well.

Mark Vickery headshot

Netflix, Intuitive Beat Q3 Earnings Easily

by Mark Vickery

Earnings of $5.40 per share for NFLX surged past the $5.09 in the Zacks consensus, demonstrating +45% growth year over year.

Intuitive Surgical, Inc. (ISRG) Beats Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Intuitive Surgical (ISRG) delivered earnings and revenue surprises of 11.52% and 1.17%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Mark Vickery headshot

Small-Cap Russell Dominates Stock Market Hump Day

by Mark Vickery

Many stocks in the Russell 2000 are small community banks, and we've seen big banks perform very well overall so far in Q3 earnings season.

Will Intuitive Surgical (ISRG) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Intuitive Surgical (ISRG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Should ISRG Stock Be Part of Your Portfolio Ahead of Q3 Earnings?

by Zacks Equity Research

Intuitive Surgical's third-quarter results are likely to reflect solid performance in the company's Instruments & Accessories segment. Improving margins buoy optimism.

Are Medical Stocks Lagging Brainsway (BWAY) This Year?

by Zacks Equity Research

Here is how Brainsway Ltd. Sponsored ADR (BWAY) and Intuitive Surgical, Inc. (ISRG) have performed compared to their sector so far this year.

Intuitive Surgical (ISRG) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

by Zacks Equity Research

Besides Wall Street's top -and-bottom-line estimates for Intuitive Surgical (ISRG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.